Paper38802435
In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.
Angermair S and 11 others. Sci Rep, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study. Papers, record 38802435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38802435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In-hospital survival of critically ill COVID-19 patients treated with glucocorticoids: a multicenter real-world data study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Critical Illness | Major topic |
| Glucocorticoids | Major topic |
| COVID-19 | Major topic |
| COVID-19 Drug Treatment | Major topic |
| Hospital Mortality | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Middle Aged | |
| Retrospective Studies | |
| Intensive Care Units | |
| Dexamethasone | |
| SARS-CoV-2 | |
| Aged, 80 and over |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32678530 | Dexamethasone in Hospitalized Patients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/32678530 | PubMed |
| 2 | 33692120 | Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. | Eur Respir J | 2021 | https://conductscience.org/library/papers/33692120 | PubMed |
| 3 | 34172464 | Steroid use in elderly critically ill COVID-19 patients. | Eur Respir J | 2021 | https://conductscience.org/library/papers/34172464 | PubMed |
| 4 | 35090528 | Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients. | Crit Care | 2022 | https://conductscience.org/library/papers/35090528 | PubMed |
| 5 | 34837648 | Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial. | Pharmacol Rep | 2022 | https://conductscience.org/library/papers/34837648 | PubMed |
| 6 | 38320047 | Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen. | NEJM Evid | 2023 | https://conductscience.org/library/papers/38320047 | PubMed |
| 7 | 32876695 | Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/32876695 | PubMed |
| 8 | 33876268 | Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. | Intensive Care Med | 2021 | https://conductscience.org/library/papers/33876268 | PubMed |
| 9 | 34781004 | Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March-12 June 2020: which interventions are proving effective in fragile states? | Int J Infect Dis | 2022 | https://conductscience.org/library/papers/34781004 | PubMed |
| 10 | 36190994 | Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial. | PLoS One | 2022 | https://conductscience.org/library/papers/36190994 | PubMed |
| 11 | 33317589 | Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. | Crit Care | 2020 | https://conductscience.org/library/papers/33317589 | PubMed |
| 12 | 33150472 | Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. | Intensive Care Med | 2020 | https://conductscience.org/library/papers/33150472 | PubMed |
| 13 | 33728167 | Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients. | Cureus | 2021 | https://conductscience.org/library/papers/33728167 | PubMed |
| 14 | 32887691 | A living WHO guideline on drugs for covid-19 | BMJ | 2020 | https://conductscience.org/library/papers/32887691 | PubMed |
| 15 | 18762788 | Genomic and nongenomic effects of glucocorticoids. | Nat Clin Pract Rheumatol | 2008 | https://conductscience.org/library/papers/18762788 | PubMed |
| 16 | 28192415 | Immune regulation by glucocorticoids. | Nat Rev Immunol | 2017 | https://conductscience.org/library/papers/28192415 | PubMed |
| 17 | 16490890 | Corticosteroid use in the intensive care unit: at what cost? | Arch Surg | 2006 | https://conductscience.org/library/papers/16490890 | PubMed |
| 18 | 36030796 | Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. | Lancet Infect Dis | 2023 | https://conductscience.org/library/papers/36030796 | PubMed |
| 19 | 32876697 | Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/32876697 | PubMed |
| 20 | 32876694 | Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. | JAMA | 2020 | https://conductscience.org/library/papers/32876694 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40465794 | In-hospital mortality outcomes of favipiravir in patients with moderate to severe COVID-19 infection: An emulated target trial using real-world data from the largest field hospital in Thailand. | PLoS One | 2025 | https://conductscience.org/library/papers/40465794 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38802435
GET https://conductscience.org/api/papers/v1/38802435/references?page=2